NUR INK INNOVATIONS LTD (IL:NURI)
TASE:NURI
Top Page
Nur
(TASE:NURI)
Select Model
Select Model
Rating:41Neutral
Price Target:
828.00
▼(-37.84% Downside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by weak financial performance (large ongoing losses, negative gross profit, and persistent cash burn), reinforced by bearish technicals (price below key moving averages with negative MACD). Valuation provides limited support because the negative P/E reflects losses and no dividend yield data is available.
Positive Factors
Low leverage / equity cushion
The company’s very low debt versus a meaningful equity base provides financial flexibility and lowers near-term solvency risk. An improving debt-to-equity trend suggests capacity to fund operations, absorb losses or invest in commercialization without urgent refinancing over the next several months.
Negative Factors
Deep unprofitability
Persistent negative gross profit implies unit economics currently do not cover direct costs, a structural issue that undermines path to sustainable profitability. Large operating losses erode retained capital and mean the business must address pricing, costs or product mix to become viable over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / equity cushion
The company’s very low debt versus a meaningful equity base provides financial flexibility and lowers near-term solvency risk. An improving debt-to-equity trend suggests capacity to fund operations, absorb losses or invest in commercialization without urgent refinancing over the next several months.
Read all positive factors
Nur (NURI) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪62.38M
Dividend YieldN/A
Average Volume (3M)6.96K
Price to Earnings (P/E)―
Beta (1Y)0.50
Revenue GrowthN/A
EPS GrowthN/A
CountryIL
Employees15
SectorTechnology
Sector Strength88
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,659,280
10 Day Avg. Volume4,577
30 Day Avg. Volume6,963
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)5.13
Price to Sales (P/S)265.22
P/FCF Ratio-11.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nur Business Overview & Revenue Model
Company Description
Nur Ink Innovations Ltd engages in the design, development, production, and sale water-based pigmented inks for digital inkjet printing applications in Israel. It offers Digital Sol-Gel, a water-based pigment inks for digital printing; and white w...
Nur Financial Statement Overview
Summary
Income Statement
9
Very Negative
Balance Sheet
54
Neutral
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 327.00K | 253.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -3.06M | -2.69M | -1.72M | -84.00 | -137.00 |
| EBITDA | -6.99M | -7.56M | -11.35K | -10.18M | -7.07M |
| Net Income | -9.42M | -9.66M | -12.86M | -11.61M | -7.78M |
Balance Sheet | |||||
| Total Assets | 22.74M | 18.39M | 21.83K | 33.29K | 41.07K |
| Cash, Cash Equivalents and Short-Term Investments | 4.14M | 5.63M | 10.44K | 21.33K | 32.90K |
| Total Debt | 2.17M | 2.70M | 2.70K | 3.12K | 3.51K |
| Total Liabilities | 5.84M | 5.56M | 5.76K | 5.48K | 5.28K |
| Stockholders Equity | 16.90M | 12.83M | 16.08K | 27.80K | 35.80K |
Cash Flow | |||||
| Free Cash Flow | -7.85M | -7.13M | -10.17K | -8.09K | -9.12K |
| Operating Cash Flow | -7.50M | -6.61M | -9.32K | -6.27K | -6.34K |
| Investing Cash Flow | -155.00K | 418.00K | 485.00 | -14.40K | -3.31K |
| Financing Cash Flow | 10.04M | 5.22M | -447.00 | -385.00 | 42.39K |
Nur Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ₪35.52M | -0.68 | ― | ― | -42.73% | 11.43% | |
51 Neutral | ₪33.66M | ― | ― | ― | -23.68% | 31.97% | |
42 Neutral | ₪162.22M | -0.40 | ― | ― | 36.26% | 43.84% | |
41 Neutral | ₪62.38M | -9.21 | ― | ― | ― | ― |
* Technology Sector Average
IL:NURI
Nur
821.40
227.50
38.31%
IL:TEDE
Tedea
389.80
-35.00
-8.24%
IL:BLITZ.M
Blitz-M
412.70
-259.00
-38.56%
IL:NRGN
Nrgene
252.30
-32.70
-11.47%
IL:ZOOZ
ZOOZ Strategy Ltd
98.70
-560.90
-85.04%
IL:MSVT
Massivit
154.10
50.47
48.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.